Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bárbara Gomes,Barion

第一单位： Universidade de Sao Paulo (USP), Sao Paulo, Brazil.

作者： Bárbara Gomes,Barion ^[1] ; Tania Rubia Flores da,Rocha ^[2] ; Yeh-Li,Ho ^[2] ; Bruna de Moraes,Mazetto Fonseca ^[3] ; Erica,Okazaki ^[2] ; Cynthia,Rothschild ^[2] ; Bianca,Stefanello ^[2] ; Vanderson Geraldo,Rocha ^[2] ; Paula Ribeiro,Villaça ^[2] ; Fernanda A,Orsi ^[4]

作者单位： Universidade de Sao Paulo (USP), Sao Paulo, Brazil. ^[1] Hospital das Clínicas da Faculdade de Medicina da Universidade de São (HCFMUSP), Sao Paulo, Brazil. ^[2] Hematology and Hemotherapy Center of the University of Campinas (UNICAMP), Campinas, Brazil. ^[3] Hospital das Clínicas da Faculdade de Medicina da Universidade de São (HCFMUSP), Sao Paulo, Brazil; Department of Pathology, School of Medical Sciences, Universidade de Campinas (UNICAMP), Campinas, Brazil. Electronic address: ferorsi@unicamp.br. ^[4]

关键词 Biomarkers COVID-19 Extracellular vesicles Hypercoagulability Inflammation

DOI 10.1016/j.htct.2023.12.003

PMID 38341321

发布时间 2024-06-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Hematology, transfusion and cell therapy

176-185页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity.

Hematology, transfusion and cell therapy

相似文献

Hematology, transfusion and cell therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Extracellular vesicles are a late marker of inflammation, hypercoagulability and COVID-19 severity.

Hematology, transfusion and cell therapy

相似文献

Hematology, transfusion and cell therapy

相关期刊

检索历史清除